Streptococcus pneumoniae remains the leading cause of bacterial meningitis.
While a new vaccine against this organism is now available, its impact on
disease is not yet known. Strategies to guide the evaluation of patients an
d the treatment of antibiotic-resistant strains can help to improve outcome
s in this dangerous disease.